20 21 Patients with NASH and liver fibrosis have quite significant healthcare consumption and spending. 22 23 The objective of our study is to determine the association of sarcopenia and liver fibrosis and steatohepatitis in NAFLD, which could provide important data to collect in future intervention or treatment studies.
← all excerpts
Association of sarcopenia with liver fibrosis and steatohepatitis in non-alcoholic fatty liver disease: protocol for a systematic review and meta-analysis.
1
—
—